Citation:Shen WY, Ji J, Zuo YS, Pu J, Xu YM, Zong CD, et al 2013

From Cancer Guidelines Wiki

Citation


Shen WY, Ji J, Zuo YS, Pu J, Xu YM, Zong CD, et al. Comparison of efficacy for postoperative chemotherapy and concurrent radiochemotherapy in patients with IIIA-pN2 non-small cell lung cancer: An early closed randomized controlled trial. Radiother Oncol 2013 Oct 31 Available from: http://www.ncbi.nlm.nih.gov/pubmed/24183868.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Shen WY, Ji J, Zuo YS, Pu J, Xu YM, Zong CD, et al 2013What is the clinical benefit of adjuvant chemotherapy for patients with stage III operable NSCLC?Professor Michael Brown MBBS PhD FRACP FRCPAcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the clinical benefit of adjuvant chemotherapy for patients with stage III operable NSCLC?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the clinical benefit of adjuvant chemotherapy for patients with stage III operable NSCLC?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Emma.dickins/Sandbox
  2. What is the clinical benefit of adjuvant chemotherapy for patients with stage III operable NSCLC?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Shen_WY,_Ji_J,_Zuo_YS,_Pu_J,_Xu_YM,_Zong_CD,_et_al_2013&oldid=68635"